共 285 条
[1]
Petty RE(1998)Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997 J Rheumatol 25 1991-1994
[2]
Southwood TR(2007)Juvenile idiopathic arthritis Rheum Dis Clin N Am 33 441-470
[3]
Baum J(2012)2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis Arthritis Care Res (Hoboken) 64 625-639
[4]
Bhettay E(2010)Methotrxate in the therapy of juvenile idiopathic arthritis Z Rheumatol 69 496-504
[5]
Glass DN(2000)MTX in juvenile idiopathic arthritis: answers and questions J Rheumatol 27 1830-1833
[6]
Manners P(2004)A randomized trial of parenteral methotrexate comparing an intermediate dose with higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate Arthritis Rheum 50 2191-2201
[7]
Maldonado-Cocco J(2010)The use of methotrexate in children with rheumatic disease Clin Exp Rheumatol 28 122-127
[8]
Suarez-Almazor M(2009)Safety and efficacy of combination of etanercept and Methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA registry Ann Rheum Dis 68 519-525
[9]
Orozco-Alcala J(2010)Methotrexate is protective against the new onset of uveitis under etanercept treatment: data from the German etanercept Registry Ann Rheum Dis 69 3-376
[10]
Prieur AM(2013)Update on biologicals for treatment of juvenile idiopathic arthritis Expert Opin Biol Ther 13 361-1356